Boehringer Ingelheim and Takeda are the only two pharmaceutical ... companies that enrich the workplace environment. Run by the Netherlands-headquartered Top Employers Institute, the annual ...

Boehringer Ingelheim As one of the industry's top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need.

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...